Fat intake and fatty acid profile in plasma phospholipids and adipose tissue in patients with Crohn's disease, compared with controls

American Journal of Gastroenterology

Volumn 94, Issue 2, 1999, Pages 410-417

  Geerling, B J ^a   Houwelingen, A C ^b   Badart Smook, A ^a   Stockbrugger R D R W ^a   Brummer, R J M ^b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CLUPANODONIC ACID; DOCOSAHEXAENOIC ACID; FATTY ACID; LINOLEIC ACID; LINOLENIC ACID; OMEGA 3 FATTY ACID; PHOSPHOLIPID; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ADULT; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; FAT INTAKE; FEMALE; HUMAN; HUMAN TISSUE; LIPID COMPOSITION; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL;

ADIPOSE TISSUE; ADULT; CASE-CONTROL STUDIES; CROHN DISEASE; DIETARY FATS; FATTY ACIDS; FEMALE; HUMANS; MALE; PHOSPHOLIPIDS; ZINC;

EID: 0033083060     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(98)00750-3     Document Type: Article

References (46)

1. Rask-Madsen J. Eicosanoids in inflammatory bowel disease: Advances, pitfalls and therapeutic consequences. Eur J Gastroenterol Hepatol 1989:1:133-65.
2. Lands WEM. Biosynthesis of prostaglandins. Annu Rev Nutr 1991; 11:41-60.
3. Shoda R, Matsueda K, Yamato S, et al. Therapeutic efficiency of n-3 polyunsaturated fatty acid in experimental Crohn's disease. J Gastroenterol 1995;30:98-101.
4. Campbell JM, Fahey GC, Lichtensteiger CA, et al. An enteral formula containing fish oil, indigestible oligosaccharides, gum arabic and antioxidants affects plasma and colonic phospholipid fatty acid and prostaglandin profiles in pigs. J Nutr 1997;127:137-45.
5. Matè J, Castanos J, Garcia-Samaniego S, et al. Does dietary fish oil maintain the remission of Crohn's disease: A study case control. Gastroenterol 1993;100:A228.
6. Lorenz-Meyer H, Bauer P, Nicolay C, et al. Omega-3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease. Scand J Gastroenterol 1996;31:778-85.
7. Belluzi A, Brignola C, Campieri M, et al. Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Eng J Med 1996;334:1557-60.
8. Siguel EN, Lerman RH. Prevalence of essential fatty acid deficiency in patients with chronic gastrointestinal disorders. Metabolism 1996;45:12-23.
9. Jeppesen PB, Christensen MS, Høy CE, et al. Essential fatty acid deficiency in patients with severe fat malabsorption. Am J Clin Nutr 1997;65:837-43.
10. Fernandez-Bañares F, Abad-Lacruz A, Xiol X, et al. Vitamin status in patients with inflammatory bowel disease. Am J Gastroenterol 1989; 84:744-8.
11. Fernandez-Bañares F, Mingorance MD, Esteve M, et al. Serum zinc, copper, and selenium levels in inflammatory bowel disease: Effect of total enteral nutrition on trace element status. Am J Gastroenterol 1990;85:1584-9.
12. Kuroki F, Lida M, Tominaga M, et al. Multiple vitamin status in Crohn's disease. Correlation with disease activity. Dig Dis Sci 1993; 38:1614-8.
13. Stokes MA. Crohn's disease and nutrition. Br J Surg 1992;79:391-4.
14. Zurita VF, Rawls DE, Dyck WP. Nutritional support in inflammatory bowel disease. Dig Dis 1995;503:92-107.
15. Geerling BJ, Badart-Smook A, Stockbriigger RW, et al. Comprehensive nutritional status in patients with long-standing Crohn's disease currently in remission. Am J Clin Nutr 1998;67:919-26.
16. Belluzi A, Brignola C, Campieri M, et al. Short report: Zinc sulphate supplementation corrects abnormal erythrocyte membrane long-chain fatty acid composition in patients with Crohn's disease. Aliment Pharmacol Ther 1994;8:127-30.
17. Cabré E, Periago JL, Mingorance MD, et al. Factors related to the plasma fatty acid profile in healthy subjects, with special reference to antioxidant micronutrient status: A multivariate analysis. Am J Clin Nutr 1992;55:831-7.
18. Esteve-Comas M, Ramírez M, Fernandez-Bañares F, et al. Plasma polyunsaturated fatty acid pattern in active inflammatory bowel disease. Gut 1992;33:1365-9.
19. Esteve-Comas M, Nuñez MC, Femandez-Bañares F, et al. Abnormal plasma polyunsaturated fatty acid pattern in non-active inflammatory bowel disease. Gut 1993;34:1370-3.
20. Johansson C, Walldius G, Rössner S. Fatty acid composition in serum lipids and adipose tissue in patients with morbus Crohn after ileal resection. Digestion 1987;37:171-7.
21. Färkkilä MA, Tilvis RS, Miettinen TA. Plasma fatty acid composition in patients with ileal dysfunction. Scand J Gastroenterol 1987;22:411-9.
22. Tribl B, Frotz S, Widhalm F, et al. Serum fatty acid pattern in patients with Crohn's disease. Clin Nutr 1988;7(suppl):80.
23. Kuroki F, Lida M, Matsumoto T, et al. Serum n3 polyunsaturated fatty acid are depleted in Crohn's disease. Dig Dis Sei 1997;42:1137-41.
24. Pereira SP, Cassell TB, Engelman JL, et al. Plasma arachidonic acid-rich phospholipids in Crohn's disease: Response to treatment. Clin Sci 1996;91:509-12.
25. Bjerve KS, Brubakk AM, Fougner KJ, et al. Omega-3 fatty acids: Essential fatty acids with important biological effects, and serum phospholipid fatty acid as markers of dietary u3-fatty acid intake. Am J Clin Nutr 1993;57(suppl):801s-6s.
26. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol 1989;24(suppl 170):2-6.
27. Best WR, Becktel JM, Singleton W. Rederived values of the eight coefficients of the Crohn's disease activity index (CDAI). Gastroenterol 1979;77:843-6.
28. van Hees PA, van Eiteren PH, van Lier HJ, et al. An index of inflammatory activity in patients with Crohn's disease. Gut 1980;21:279-86.
29. Beal VA. The nutritional history in longitudinal research. J Am Diet Assoc 1967;51:426-32.
30. Cameron ME, Staveren van WA. Manual on methodology for food consumption studies. Oxford: Oxford Medical Publications, 1988.
31. Al MDM, Badart-Smook A, v Houwelingen AC, et al. Fat intake of women during normal pregnancy: Relationship with maternal and neonatal essential fatty acid status. J Am Coll Nutr 1996;15:49-55.
32. NEVO Foundation. Dutch food composition table 1989-1990. Voorlichtingsbureau voor de Voeding. The Hague, The Netherlands (in Dutch).
33. Bligh EG, Dyer WJ. A rapid method for total lipid extraction and purification. Can J Biochem Physiol 1959;37:911-7.
34. Kaluzny MA, Duncan LA, Meritt MV, et al. Rapid separation of lipid classes in high yield and purity using bonded phase columns. J Lipid Res 1985:26:135-40.
35. Morrison WR, Smith LM. Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride methanol. J Lipid Res 1964;5:600-8.
36. Hornstra G. Essential fatty acids, pregnancy and pregnancy complications: A round table discussion. In: Sinclair A, Gibson R, eds. Essential fatty acids and eicosanoids. Invited papers from the third international congress. Champaign, IL: Am Oil Chem Soc, 1992:177-82.
37. Holman RT. The ratio of trienoic:tetraenoic acids in tissue lipids as a measure of essential fatty acid requirement. J Nutr 1960:70:405-10.
38. Bühner S, Nagel E, Körber J, et al. Ileal and colonie fatty acid profiles in patients with active Crohn's disease. Gut 1994:35:1424-8.
39. Esteve-Comas M, Navarro E, Femandez-Bañares F, et al. Mucosal fatty acid pattern in inflammatory bowel disease patients. Clin Nutr 1997;16(suppl 2):A45.
40. Brenner RR. Nutritional and hormonal factors influencing desaturation of essential fatty acids. Prog Lipid Res 1981;20:41-7.
41. De Craemer D, Pauwels M, van den Branden C. Dietary docosahexaenoic acid has little effect on peroxisomes in healthy mice. Lipids 1996:31:1157-61.
42. Hill EG, Holman RT. Effect of dietary protein level upon essential fatty acid deficiency. J Nutr 1980; 110:1057-60.
43. Tomas ME, Mercuri O, Rodrigo A. Effects of dietary protein and EFA deficiency on liver Δ5, Δ6 and Δ9 desaturase activities in the early developing rat. J Nutr 1980; 110:595-9.
44. Wolff JA, Margolis S, Bujdoso-Wolff K, et al. Plasma and red blood cell fatty acid composition in children with protein-calorie malnutrition. Pediatr Res 1984;18:162-6.
45. Clejan S, Castro-Magna M, Collip PJ, et al. Effects of zinc deficiency and castrastion on fatty acid composition and desaturation in rats. Lipids 1982; 17:129.
46. Dias VC, Parsons HG. Modulation in Δ9, Δ6, and Δ5 fatty acid desaturase activity in the human intestinal CaCo-2 cell line. J Lipid Res 1995;36:552-63.